TRDA CLUSTER SEC Filing Analysis

Final — all horizons settled through T+60d

TRDA ▼ -45.44% at T+60d

NEUTRAL call ✗ call lost -45.44% · α vs SPY -55.53% · entry $12.50 → $6.82

Currently $6.46 · -48.32% from $12.50 entry

Entry anchored
Mar 3, 03:59 PM ET
via Databento tick

T+1d

-7.04%

call -7.04% · α -6.47%

$11.62

settled 3mo ago

T+5d

+8.00%

call +8.00% · α +9.33%

$13.50

settled 3mo ago

T+20d

+7.84%

call +7.84% · α +12.26%

$13.48

settled 2mo ago

T+60d

-45.44%

call -45.44% · α -55.53%

$6.82

settled 16d ago

Price Chart

Loading chart...

Executive Summary

Entrada Therapeutics President & COO Nathan J. Dowden sold a total of 15,010 shares in the past week for approximately $195,771 in open-market transactions. The sales represent a modest insider divestment by a single C-suite executive.

Key Financial Metrics

Direction

selling

Total Value

$195.8K

Insiders

1

Actionable Insight

Monitor for additional insider selling in the coming weeks; single-executive sales of this size are typically routine, but could signal caution if followed by broader divestments or negative news.

Key Facts

President & COO Nathan J. Dowden sold 15,010 shares over two days (11,894 shares on 2026-03-10 at $13.0476; 3,116 shares on 2026-03-09 at $13.024).
Total proceeds from the sales were $195,770.93.
All transactions were open-market sales (Form 4 codes 'S').
No other insiders participated in this cluster.

Financial Impact

$195,771 in total sales, representing ~0.039% of company's $505M market cap

insider ownershipshare float

Risk Factors

Potential perception of insider lack of confidence if no offsetting positive developments emerge.
Concentration of selling in a short window may attract short-term trader attention despite low overall magnitude.

Market Snapshot

Exchange

Nasdaq

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CONTEXT: Insider Cluster Data (2 trades, 7d window)	cluster-TRDA-1773261430415

8 reports for TRDA

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for TRDA — sortable, filterable
	Type				Now
Jun 10, 2026 2d ago	8-K NEUTRAL ★ 2/10	$5.96 awaiting T+1	awaiting T+1	—	$6.46 (+8.39%)
Jun 2, 2026 11d ago	Press Release NEUTRAL ★ 4/10	$6.64 $6.58	▼ −0.90%	▼ −0.18%	$6.46 (−2.71%)
May 7, 2026 5w ago	Press Release MIXED ★ 6/10	$6.85 $6.84	▼ −0.15%	▼ −0.98%	$6.46 (−5.69%)
May 4, 2026 5w ago	144 NEUTRAL ★ 2/10	$15.75 $16.03	▲ +1.78%	▲ +0.39%	$6.46 (−58.98%)
May 4, 2026 5w ago	Insider Cluster BEARISH ★ 5/10	$15.79 $15.75	▲ +0.25%	▲ +1.05%	$6.46 (+59.09%)
Apr 24, 2026 7w ago	DEFA14A NEUTRAL ★ 3/10	$12.63 $12.96	▲ +2.61%	▲ +2.45%	$6.46 (−48.85%)
Mar 4, 2026 14w ago	Insider Cluster NEUTRAL ★ 3/10	$12.50 $11.62	▼ −7.04%	▼ −6.47%	$6.46 (−48.32%)
Feb 26, 2026 15w ago	8-K BEARISH ★ 6/10	$12.79 $11.93	▲ +6.72%	▲ +6.27%	$6.46 (+49.49%)

US Market Status

Market Closed — Opens Mon (48h 51m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access